Edelman Joseph's Form 4 filing
Soleno Therapeutics Inc (SLNO) ยท filed Sep 28, 2023
- Accession no.
- 0001062993-23-018574
- Filed
- Sep 28, 2023, 3:45 PM ET
- Trade date
- Sep 26-28, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 15 non-derivative transactions and 1 derivative transaction. Open-market purchases total $15.1M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edelman JosephCIK 0001164426 | 10% Owner |
| Perceptive Advisors LLCCIK 0001224962 | 10% Owner |
| Perceptive Life Sciences Master Fund LtdCIK 0001249675 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +5,703 | $7.65F2,F3 | +$43,627.95 | 2,213,456 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +13,687 | $8.30F2,F4 | +$113,602.1 | 2,227,143 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +5,419 | $9.52F2,F5 | +$51,588.88 | 2,232,562 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +37,911 | $11.05F2,F6 | +$418,916.55 | 2,270,473 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +77,837 | $11.81F2,F7 | +$919,254.97 | 2,348,310 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +42,838 | $12.84F2,F8 | +$550,039.92 | 2,391,148 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +30,511 | $13.92F2,F9 | +$424,713.12 | 2,421,659 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +3,326 | $14.61F2,F10 | +$48,592.86 | 2,424,985 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +27,769 | $16.00F2,F11 | +$444,304 | 2,452,754 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +75,477 | $17.28F2,F12 | +$1,304,242.56 | 2,528,231 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +52,691 | $18.24F2,F13 | +$961,083.84 | 2,580,922 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +88,685 | $19.11F2,F14 | +$1,694,770.35 | 2,669,607 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +117,996 | $20.03F2,F15 | +$2,363,459.88 | 2,787,603 | Indirect | |
| Sep 26, 2023 | Common Stock | PPurchaseAcquired | +36,939 | $21.00F2,F16 | +$775,719 | 2,824,542 | Indirect | |
| Sep 28, 2023 | Common Stock | PPurchaseAcquired | +250,000 | $20.00F17 | +$5,000,000 | 3,074,542 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2023 | Common Stock | PPurchaseAcquired | +250,000 | $19.99 | +$4,997,500 | 250,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges of the prices reported.
Referenced by the price of 14 transactions in Table I.
- F3
These shares were purchased in multiple transactions at prices ranging from $6.95 to $7.87, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
These shares were purchased in multiple transactions at prices ranging from $8.00 to $8.89, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
These shares were purchased in multiple transactions at prices ranging from $9.32 to $9.73, inclusive.
Referenced by the price of 1 transaction in Table I.
- F6
These shares were purchased in multiple transactions at prices ranging from $10.39 to $11.38, inclusive.
Referenced by the price of 1 transaction in Table I.
- F7
These shares were purchased in multiple transactions at prices ranging from $11.39 to $12.40, inclusive.
Referenced by the price of 1 transaction in Table I.
- F8
These shares were purchased in multiple transactions at prices ranging from $12.41 to $13.40, inclusive.
Referenced by the price of 1 transaction in Table I.
- F9
These shares were purchased in multiple transactions at prices ranging from $13.42 to $14.41, inclusive.
Referenced by the price of 1 transaction in Table I.
- F10
These shares were purchased in multiple transactions at prices ranging from $14.42 to $15.00, inclusive.
Referenced by the price of 1 transaction in Table I.
- F11
These shares were purchased in multiple transactions at prices ranging from $15.66 to $16.50, inclusive.
Referenced by the price of 1 transaction in Table I.
- F12
These shares were purchased in multiple transactions at prices ranging from $16.70 to $17.695, inclusive.
Referenced by the price of 1 transaction in Table I.
- F13
These shares were purchased in multiple transactions at prices ranging from $17.70 to $18.69, inclusive.
Referenced by the price of 1 transaction in Table I.
- F14
These shares were purchased in multiple transactions at prices ranging from $18.70 to $19.69, inclusive.
Referenced by the price of 1 transaction in Table I.
- F15
These shares were purchased in multiple transactions at prices ranging from $19.70 to $20.69, inclusive.
Referenced by the price of 1 transaction in Table I.
- F16
These shares were purchased in multiple transactions at prices ranging from $20.70 to $21.40, inclusive.
Referenced by the price of 1 transaction in Table I.
- F17
Purchased in the Issuer's registered public offering scheduled to close on October 2, 2023.
Referenced by the price of 1 transaction in Table I.